The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Emerging Links between Nonalcoholic Fatty Liver Disease and Neurodegeneration
Semin Liver Dis. 2023 Feb;43(1):77-88. doi: 10.1055/s-0043-1762585.Epub 2023 Feb 10.
1Department of Biomedical Sciences, University of Missouri - Columbia, Columbia, Missouri.
2Department of Nutrition and Exercise Physiology, University of Missouri - Columbia, Columbia, Missouri.
3NextGen Precision Health, University of Missouri - Columbia, Columbia, Missouri.
4Comparative Medicine Program, University of Missouri - Columbia, Columbia, Missouri.
5Physical Medicine and Rehabilitation, University of Missouri - Columbia, Columbia, Missouri.
6Research Service, Harry S. Truman Memorial Veterans' Hospital, Columbia, Missouri.
7Division of Gastroenterology and Hepatology, Department of Medicine, University of Missouri - Columbia, Columbia, Missouri.
Abstract
The association between liver and brain health has gained attention as biomarkers of liver function have been revealed to predict neurodegeneration. The liver is a central regulator in metabolic homeostasis. However, in nonalcoholic fatty liver disease (NAFLD), homeostasis is disrupted which can result in extrahepatic organ pathologies. Emerging literature provides insight into the mechanisms behind the liver-brain health axis. These include the increased production of liver-derived factors that promote insulin resistance and loss of neuroprotective factors under conditions of NAFLD that increase insulin resistance in the central nervous system. In addition, elevated proinflammatory cytokines linked to NAFLD negatively impact the blood-brain barrier and increase neuroinflammation. Furthermore, exacerbated dyslipidemia associated with NAFLD and hepatic dysfunction can promote altered brain bioenergetics and oxidative stress. In this review, we summarize the current knowledge of the crosstalk between liver and brain as it relates to the pathophysiology between NAFLD and neurodegeneration, with an emphasis on Alzheimer's disease. We also highlight knowledge gaps and future areas for investigation to strengthen the potential link between NAFLD and neurodegeneration.